{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:51:37Z","timestamp":1781596297010,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41401-025-01720-6","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:41:19Z","timestamp":1768556479000},"page":"1351-1360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cryo-EM structures of GPR75 reveal an occluded orthosteric pocket challenging conventional drug discovery paradigms for an anti-obesity target"],"prefix":"10.1038","volume":"47","author":[{"given":"Zi-ning","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-zhao","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-ning","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiu-yin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-yue","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Jiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-chao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Eric","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can-rong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"1720_CR1","unstructured":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402:203\u201334."},{"key":"1720_CR2","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, Despr\u00e9s JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143: e984\u2013e1010.","journal-title":"Circulation"},{"key":"1720_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.21037\/atm.2017.03.107","volume":"5","author":"M Abdelaal","year":"2017","unstructured":"Abdelaal M, le Roux CW, Docherty NG. Morbidity and mortality associated with obesity. Ann Transl Med. 2017;5:161.","journal-title":"Ann Transl Med"},{"key":"1720_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/biom15020291","volume":"15","author":"YY Cho","year":"2015","unstructured":"Cho YY, Kim S, Kim P, Jo MJ, Park SE, Choi Y, et al. G-Protein-Coupled Receptor (GPCR) signaling and pharmacology in metabolism: physiology, mechanisms, and therapeutic potential. Biomolecules. 2015;15:291.","journal-title":"Biomolecules"},{"key":"1720_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.984253","volume":"13","author":"LF Barella","year":"2022","unstructured":"Barella LF, Jain S, Pydi SP. G protein-coupled receptors: role in metabolic disorders. Front Endocrinol (Lausanne). 2022;13:984253.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1720_CR6","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1056\/NEJMc2211120","volume":"387","author":"A Venniyoor","year":"2022","unstructured":"Venniyoor A. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:1433\u20134.","journal-title":"N Engl J Med"},{"key":"1720_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1056\/NEJMoa2416394","volume":"393","author":"LJ Aronne","year":"2025","unstructured":"Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Gomez Valderas E, et al. Tirzepatide as compared with semaglutide for the treatment of obesity. N Engl J Med. 2025;393:26\u201336.","journal-title":"N Engl J Med"},{"key":"1720_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/jcm12010145","volume":"12","author":"JJ Gorgojo-Mart\u00ednez","year":"2022","unstructured":"Gorgojo-Mart\u00ednez JJ, Mezquita-Raya P, Carretero-G\u00f3mez J, Castro A, Cebri\u00e1n-Cuenca A, de Torres-S\u00e1nchez A, et al. Clinical recommendations to manage gastrointestinal adverse events in patients treated with Glp-1 receptor agonists: a multidisciplinary expert consensus. J Clin Med. 2022;12:145.","journal-title":"J Clin Med"},{"key":"1720_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf8683","volume":"373","author":"P Akbari","year":"2021","unstructured":"Akbari P, Gilani A, Sosina O, Kosmicki JA, Khrimian L, Fang YY, et al. Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity. Science. 2021;373:eabf8683.","journal-title":"Science"},{"key":"1720_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41588-024-01694-x","volume":"56","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Chukanova M, Kentistou KA, Fairhurst-Hunter Z, Siegert AM, Jia RY, et al. Protein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease. Nat Genet. 2024;56:579\u201384.","journal-title":"Nat Genet"},{"key":"1720_CR11","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/oby.23692","volume":"31","author":"S Hossain","year":"2023","unstructured":"Hossain S, Gilani A, Pascale J, Villegas E, Diegisser D, Agostinucci K, et al. Gpr75-deficient mice are protected from high-fat diet-induced obesity. Obesity (Silver Spring). 2023;31:1024\u201337.","journal-title":"Obesity (Silver Spring)"},{"key":"1720_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI182121","volume":"134","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Xun Y, Zhang Z. Central regulation of feeding and body weight by ciliary GPR75. J Clin Invest. 2024;134:e182121.","journal-title":"J Clin Invest"},{"key":"1720_CR13","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.cmet.2024.03.016","volume":"36","author":"A Leeson-Payne","year":"2024","unstructured":"Leeson-Payne A, Iyinikkel J, Malcolm C, Lam BYH, Sommer N, Dowsett GKC, et al. Loss of GPR75 protects against non-alcoholic fatty liver disease and body fat accumulation. Cell Metab. 2024;36:1076\u201387.","journal-title":"Cell Metab"},{"key":"1720_CR14","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/ijo.2008.102","volume":"32","author":"T Kelly","year":"2008","unstructured":"Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008;32:1431\u20137.","journal-title":"Int J Obes (Lond)"},{"key":"1720_CR15","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.3390\/ijms26094084","volume":"26","author":"J Han","year":"2025","unstructured":"Han J, Li J, Yao S, Wei Z, Jiang H, Xu T, et al. GPR75: advances, challenges in deorphanization, and potential as a novel drug target for disease treatment. Int J Mol Sci. 2025;26:4084.","journal-title":"Int J Mol Sci"},{"key":"1720_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107928","volume":"228","author":"P Atanes","year":"2021","unstructured":"Atanes P, Ashik T, Persaud SJ. Obesity-induced changes in human islet G protein-coupled receptor expression: implications for metabolic regulation. Pharmacol Ther. 2021;228:107928.","journal-title":"Pharmacol Ther"},{"key":"1720_CR17","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.31557\/APJCP.2023.24.5.1817","volume":"24","author":"MR Dashti","year":"2023","unstructured":"Dashti MR, Gorbanzadeh F, Jafari-Gharabaghlou D, Farhoudi Sefidan Jadid M, Zarghami N. G protein-coupled receptor 75 (GPR75) as a novel molecule for targeted therapy of cancer and metabolic syndrome. Asian Pac J Cancer Prev. 2023;24:1817\u201325.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1720_CR18","doi-asserted-by":"publisher","first-page":"e0247743","DOI":"10.1371\/journal.pone.0247743","volume":"16","author":"S Lu","year":"2021","unstructured":"Lu S, Jang W, Inoue A, Lambert NA. Constitutive G protein coupling profiles of understudied orphan GPCRs. PLoS One. 2021;16:e0247743.","journal-title":"PLoS One"},{"key":"1720_CR19","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1161\/CIRCRESAHA.116.310525","volume":"120","author":"V Garcia","year":"2017","unstructured":"Garcia V, Gilani A, Shkolnik B, Pandey V, Zhang FF, Dakarapu R, et al. 20-HETE signals through G-protein-coupled receptor GPR75 (Gq) to affect vascular function and trigger hypertension. Circ Res. 2017;120:1776\u201388.","journal-title":"Circ Res"},{"key":"1720_CR20","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","volume":"596","author":"K Tunyasuvunakool","year":"2021","unstructured":"Tunyasuvunakool K, Adler J, Wu Z, Green T, Zielinski M, \u017d\u00eddek A, et al. Highly accurate protein structure prediction for the human proteome. Nature. 2021;596:590\u20136.","journal-title":"Nature"},{"key":"1720_CR21","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60:2126\u201332.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"1720_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1107\/S0909049503024130","volume":"11","author":"PD Adams","year":"2004","unstructured":"Adams PD, Gopal K, Grosse-Kunstleve RW, Hung LW, Ioerger TR, McCoy AJ, et al. Recent developments in the PHENIX software for automated crystallographic structure determination. J Synchrotron Radiat. 2004;11:53\u20135.","journal-title":"J Synchrotron Radiat"},{"key":"1720_CR23","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera\u2013a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605\u201312.","journal-title":"J Comput Chem"},{"key":"1720_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41401-022-00938-y","volume":"44","author":"XH He","year":"2023","unstructured":"He XH, You CZ, Jiang HL, Jiang Y, Xu HE, Cheng X. AlphaFold2 versus experimental structures: evaluation on G protein-coupled receptors. Acta Pharmacol Sin. 2023;44:1\u20137.","journal-title":"Acta Pharmacol Sin"},{"key":"1720_CR25","doi-asserted-by":"publisher","first-page":"D395","DOI":"10.1093\/nar\/gkac1013","volume":"51","author":"G P\u00e1ndy-Szekeres","year":"2023","unstructured":"P\u00e1ndy-Szekeres G, Caroli J, Mamyrbekov A, Kermani AA, Keser\u0171 GM, Kooistra AJ, et al. GPCRdb in 2023: state-specific structure models using AlphaFold2 and new ligand resources. Nucleic Acids Res. 2023;51:D395\u2013D402.","journal-title":"Nucleic Acids Res"},{"key":"1720_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s43556-023-00156-w","volume":"4","author":"L Cheng","year":"2023","unstructured":"Cheng L, Xia F, Li Z, Shen C, Yang Z, Hou H, et al. Structure, function and drug discovery of GPCR signaling. Mol Biomed. 2023;4:46.","journal-title":"Mol Biomed"},{"key":"1720_CR27","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41586-022-05173-3","volume":"609","author":"J Duan","year":"2022","unstructured":"Duan J, Xu P, Luan X, Ji Y, He X, Song N, et al. Hormone- and antibody-mediated activation of the thyrotropin receptor. Nature. 2022;609:854\u20139.","journal-title":"Nature"},{"key":"1720_CR28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405732121","volume":"121","author":"X Zhang","year":"2024","unstructured":"Zhang X, Schlimgen RR, Singh S, Tomani MP, Volkman BF, Zhang C. Molecular basis for chemokine recognition and activation of XCR1. Proc Natl Acad Sci USA. 2024;121:e2405732121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1720_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36170-3","volume":"14","author":"J Duan","year":"2023","unstructured":"Duan J, Xu P, Zhang H, Luan X, Yang J, He X, et al. Mechanism of hormone and allosteric agonist mediated activation of follicle stimulating hormone receptor. Nat Commun. 2023;14:519.","journal-title":"Nat Commun"},{"key":"1720_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102813118","volume":"118","author":"H Liu","year":"2021","unstructured":"Liu H, Deepak RNVK, Shiriaeva A, Gati C, Batyuk A, Hu H, et al. Molecular basis for lipid recognition by the prostaglandin D2 receptor CRTH2. Proc Natl Acad Sci USA. 2021;118:e2102813118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1720_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2403304121","volume":"121","author":"J Xu","year":"2024","unstructured":"Xu J, Xu Y, Hou L, He X, Li Y, Zhao J, et al. Molecular basis of lipid and ligand regulation of prostaglandin receptor DP2. Proc Natl Acad Sci USA. 2024;121:e2403304121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1720_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38411-x","volume":"14","author":"C Wu","year":"2023","unstructured":"Wu C, Xu Y, He Q, Li D, Duan J, Li C, et al. Ligand-induced activation and G protein coupling of prostaglandin F2\u03b1 receptor. Nat Commun. 2023;14:2668.","journal-title":"Nat Commun"},{"key":"1720_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.tcb.2024.12.006","volume":"35","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Zhang Z. Adopting GPR75 in treating obesity: unraveling the knowns and unknowns of this orphan GPCR. Trends Cell Biol. 2025;35:102\u20134.","journal-title":"Trends Cell Biol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01720-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:52:21Z","timestamp":1781592741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01720-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1720"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01720-6","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article, affiliation 7 was inadvertently omitted for Dr. Kai Wang and Dr. H. Eric Xu.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ZH, ML, and BS are employed by BioFront Therapeutics. HEX is one of the Associate Editors of APS and was not involved in the peer review or the decision making of the article. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}